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Absence of CXCR2 results in abnormal retention of neutrophils in the 


















Cxcr2–/– neutrophils are selectively 
retained in the bone marrow of mixed 
chimeras. (A) Generation of mixed 
chimeras. Bone marrow cells from WT 
and Cxcr2–/– mice (expressing Ly5.1 
and Ly5.2, respectively; 1 × 106 cells 
from each) were mixed in a 1:1 ratio 
and transplanted into lethally irradiat-
ed congenic WT recipients (express-
ing Ly5.1). Mice were analyzed 6–8 
weeks after transplantation. (B) Rep-
resentative dot plots showing the 
contribution of WT and Cxcr2–/– cells 
(with and without Ly5.1, respectively) 
to neutrophils (Gr-1hi) in the blood 
and bone marrow. (C) Quantitation 
of mature neutrophils (Gr-1hiSSChi) in 
the blood, bone marrow, and spleen. 
(D) NDI was calculated as described 
in Methods to estimate the percentage 
of total body neutrophils in the blood. 
(E) Number of B lymphocytes (B220+) 
or T lymphocytes (CD3+) in the blood 
(left) and B lymphocytes in the bone 
marrow (right). T lymphocyte chime-
rism was assessed 6 months after 
transplantation (n = 3). (F) Number of 
WT or Cxcr2–/– CFU in culture (CFU-C) 
or CFU-granulocyte (CFU-G) in the 
bone marrow (n = 3). n = 27 (blood); 
n = 6 (bone marrow and spleen) from 
at least 3 independent transplanta-
tions, unless otherwise indicated.
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CXCR2 deficiency produces a 
myelokathexis-like phenotype. (A) 
Representative dot plots of mixed 
chimera bone marrow showing the 
percentage of Gr-1hiSSChi cells 
within the total Gr-1+ myeloid cell 
population for WT and Cxcr2–/– 
cells. (B) Percent Gr-1hiSSChi 
cells within the total Gr-1+ myeloid 
cell population for n = 7 chimeric 
mice from 2 independent trans-
plants. (C) Representative photo-
micrographs of sorted WT and 
Cxcr2–/– Gr-1+ cells. Scale bars: 
20 μm. (D) Manual leukocyte dif-
ferentials of sorted cells from n = 5 
mice from 2 transplants. Blast, 
myeloblast; Band, band neutro-
phil; Seg, segmented neutrophil. 
***P < 0.001, 2-way ANOVA.
Figure 3
Mobilization of Cxcr2–/– neutrophils by G-CSF is impaired. (A) Mixed chimeras (n = 5) were given a single injection of G-CSF (125 μg/kg), and the 
absolute neutrophil count for each genotype was determined 1.5 hours after injection. (B) G-CSF (125 μg/kg/d, twice daily) was administered to 
a separate cohort of n = 5 chimeric mice for 5 days, and blood neutrophils were quantified. (C) Number of WT or Cxcr2–/– Gr-1+SSChi cells in the 
bone marrow and spleen after 5 days of G-CSF administration. (D) The calculated NDI after 5 days of G-CSF. †P < 0.05, ‡P < 0.01 versus time 0; 
**P < 0.01, ***P < 0.001 versus Cxcr2–/– at the same time point; 2-way ANOVA.
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CXCR2 antagonistically regulates CXCR4-mediated neutrophil retention 










CXCR2 and CXCR4 signals interact antagonistically to regulate neutrophil release. (A) Representative dot plots show cell surface CXCR4 
expression of WT and Cxcr2–/– Gr-1+SSChi bone marrow cells from a Cxcr2–/– mixed chimera (right), and cells treated with an isotype-matched 
antibody (left), shown as controls. Bar graphs show CXCR4 MFI and percent CXCR4+ cells from n = 5 mice. White bars, WT; black bars, Cxcr2–/–. 
(B) Cxcr2–/– mixed chimeras (n = 5) were given a single subcutaneous injection of AMD3100 (5 mg/kg), and neutrophils were quantified at the 
indicated times. (C and D) Number of neutrophils in the bone marrow and spleen (C) and NDI (D) at 1 hour after AMD3100 administration (n = 3). 
(E and F) MKO (n = 10) and DKO (n = 4) mixed chimeras were established as described in Figure 1. Blood, bone marrow, and spleen neutro-
phils (E) and NDI (F) were quantified 7 weeks after transplantation. ***P < 0.001, 1-way ANOVA. (G) MKO mixed chimeras (n = 3) were given a 
subcutaneous injection of GROβ (100 μg/kg), and the number of WT and Cxcr4–/– neutrophils in the blood was measured after 30 minutes. (B 
and G) †P < 0.05, ‡P < 0.01 versus time 0; **P < 0.01, ***P < 0.001 versus WT at the same time point; 2-way ANOVA.
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CXCR2 ligands are produced by bone marrow stromal 
cells and regulated by G-CSF. (A) Bone marrow 
endothelial cells (7AAD–CD45loTer119loCD31+) or 
osteoblasts (7AAD–CD45loTer119loGFP+) were iso-
lated by cell sorting from Col2.3:GFP transgenic mice. 
Shown are representative dot plots depicting the sort-
ing strategy. (B) Normalized gene chip signal at base-
line for all chemokines with an average signal inten-
sity of greater than 400 in at least 1 of the cell types. 
When more than 1 probe set existed, the highest 
signal was selected. Ppbp encodes for CXCL7, and 
Mif is a nonchemokine ligand for CXCR2 and CXCR4 
(60). (C) Expression of CXCR2 and CXCR4 ligands 
in endothelial cells from WT mice at baseline or after 
G-CSF administration. (D) CXCL2 protein in bone 
marrow supernatant at baseline or after G-CSF, mea-
sured by ELISA (n = 4 mice per group). The dashed 
line represents the limit of detection for the assay. 
*P < 0.05; **P < 0.01; ***P < 0.001; 2-way ANOVA.
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Tug-of-war model of neutrophil trafficking from the bone marrow. See Dis-
cussion for details.
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internalization  of  carboxy-terminus  truncated 
















CXCR4- and SDF-1-deficient mice. Proc Natl Acad 
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